Preclinical evidence for combining the 5‐ HT 2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evidence for combining the 5‐ HT 2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence

Published:2018-03-02 Issue:3 Volume:24 Page:376-387
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Fletcher Paul J.¹²³^ORCID,Li Zhaoxia¹,Silenieks Leo B.⁴,MacMillan Cam⁴,DeLannoy Ines⁴,Higgins Guy A.⁵⁴

Affiliation:

1. Section of Biopsychology & Campbell Family Mental Health Research InstituteCentre for Addiction and Mental Health Canada

2. Department of PsychiatryUniversity of Toronto Canada

3. Department of PsychologyUniversity of Toronto Canada

4. InterVivo Solutions Inc Canada

5. Department of Pharmacology and ToxicologyUniversity of Toronto Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/adb.12602

Reference50 articles.

1. Weight gain in smokers after quitting cigarettes: meta‐analysis;Aubin HJ;BMJ,2012

2. CahillK Lindson‐HawleyN ThomasKH FanshaweTR LancasterT(2016)Nicotine receptor partial agonists for smoking cessation. The Cochrane database of systematic reviews:CD006103.

3. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study;Di Giovanni G;Synapse,2000

4. Biochemical and electrophysiological evidence that Ro 60‐0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors;Di Matteo V;Brain Research,2000

5. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration;Di Matteo V;Journal of Neurochemistry,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lorcaserin: Worthy of Further Insights? Results from Recent Research;CNS & Neurological Disorders - Drug Targets;2024-03

2. Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats;International Journal of Molecular Sciences;2021-01-16

3. 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence;Progress in Brain Research;2021

4. Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence;Progress in Brain Research;2021

5. Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain;Frontiers in Pharmacology;2020-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3